This inventor holds 24 USPTO granted patents and 5 published patent applications and 18 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC, Merck + Co., Inc.. Active years: 2009-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mountainside, NJ (US) (2009 - 2016)
- New Providence, NJ (US) (2016 - 2018)
- South San Francisco, CA (US) (2019)
- Mateo, CA (US) (2022)
Company Filing History:
21 out of 2,405 
2 out of 70 
1 out of 4,770 
Years Active: 2009-2026
Areas of Expertise:
Title: Anthony K. Ogawa: A Pioneering Inventor in Biomedicine
Introduction
Anthony K. Ogawa, located in New Providence, New Jersey, is a prolific inventor with an impressive portfolio of 20 patents to his name. His contributions to the field of biomedicine have paved the way for novel treatment options in combating bacterial infections and thromboses.
Latest Patents
Ogawa's latest innovations include groundbreaking patents such as "Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections." This invention relates to biaryl monobactam compounds formulated for pharmaceutical use, comprising combinations of a therapeutically effective amount of the compounds to treat bacterial infections. Additionally, he has patented "Factor XIa inhibitors," which presents selective compounds and pharmaceutical compositions aimed at treating or preventing thromboses, embolisms, and hypercoagulability. These advancements mark significant steps in therapeutic interventions.
Career Highlights
Throughout his career, Anthony K. Ogawa has made significant contributions while working with renowned companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His expertise and innovative spirit have left a lasting impact on the pharmaceutical industry, particularly in drug development and therapeutic solutions.
Collaborations
Anthony has collaborated with esteemed professionals, including Feroze Ujjainwalla and Scott D. Edmondson. Their collective efforts have fostered advancements in pharmaceuticals, demonstrating the power of teamwork in the innovation process.
Conclusion
In summary, Anthony K. Ogawa stands out as a pivotal figure in the realm of biomedical inventions. His 20 patents and collaborative initiatives reflect a commitment to improving healthcare through innovative drug development. As he continues to contribute to scientific advancements, Ogawa's work inspires future inventors and researchers in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile